Insider Transactions in Q2 2024 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2024
|
Mark G Currie |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+4.1%
|
-
|
|
Jun 18
2024
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+14.04%
|
-
|
|
Jun 18
2024
|
Marla L Kessler |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+16.74%
|
-
|
|
Jun 18
2024
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+12.92%
|
-
|
|
Jun 18
2024
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+25.0%
|
-
|
|
Jun 18
2024
|
Jon R Duane |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+14.33%
|
-
|
|
Jun 18
2024
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+11.44%
|
-
|
|
Jun 18
2024
|
Jay Shepard |
BUY
Grant, award, or other acquisition
|
Direct |
24,311
+16.11%
|
-
|
|
Jun 15
2024
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
2,572
+2.02%
|
-
|
|
Jun 10
2024
|
Julie Mc Hugh |
SELL
Open market or private sale
|
Direct |
22,766
-14.03%
|
$136,596
$6.29 P/Share
|
|
Jun 07
2024
|
Catherine Moukheibir |
SELL
Open market or private sale
|
Direct |
35,574
-42.25%
|
$213,444
$6.61 P/Share
|
|
Jun 06
2024
|
Catherine Moukheibir |
SELL
Open market or private sale
|
Direct |
44,426
-34.54%
|
$266,556
$6.36 P/Share
|
|
May 20
2024
|
Minardo John Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
17,404
-5.58%
|
$104,424
$6.45 P/Share
|
|
May 20
2024
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
SELL
Open market or private sale
|
Direct |
16,128
-3.75%
|
$96,768
$6.45 P/Share
|
|
May 20
2024
|
Andrew Davis SVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
22,725
-7.31%
|
$136,350
$6.45 P/Share
|
|
May 20
2024
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
67,618
-5.55%
|
$405,708
$6.45 P/Share
|
|
May 16
2024
|
Sravan Kumar Emany SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,280
-5.39%
|
$109,680
$6.64 P/Share
|